Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Review and Approval of Batch Manufacturing Records (BMR) – V 2.0

Posted on By

API Manufacturing: SOP for Review and Approval of Batch Manufacturing Records (BMR) – V 2.0

Standard Operating Procedure for Review and Approval of Batch Manufacturing Records (BMR) in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/161/2025
Supersedes SOP/API/161/2022
Page No. Page 1 of 13
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To establish a standard procedure for the thorough review and systematic approval of Batch Manufacturing Records (BMRs) to ensure accuracy, completeness, regulatory compliance, and readiness for batch release in API manufacturing.

2. Scope

This SOP applies to all batches of active pharmaceutical ingredients manufactured at the facility. It

covers the responsibilities, documentation, review process, and approval hierarchy from production through Quality Assurance (QA).

3. Responsibilities

  • Production Officer: Ensure all fields in BMR are duly filled, signed, and verified during manufacturing activities.
  • QA Reviewer: Perform thorough BMR review post-manufacture and identify deviations, omissions, or errors.
  • QA Manager: Approve BMR after verification and confirm batch release readiness.
  • QC Analyst: Attach all relevant analytical data, including Certificate of Analysis (CoA), to the BMR.

4. Accountability

The Head of Quality Assurance is accountable for ensuring compliance with the BMR review procedure and that no batch is released without BMR approval.

See also  API Manufacturing: SOP for Labeling of Raw Materials with Status Tags - V 2.0

5. Procedure

5.1 BMR Preparation During Manufacturing

  1. The Production department shall fill out the BMR in real-time, using indelible ink, without overwriting.
  2. Entries must be made immediately after each activity step is completed.
  3. All sections must be signed and dated by the responsible personnel and verified by production supervisory staff.
  4. Attach all associated documents including raw material requisition, process flow diagrams, in-process test results, equipment usage logs, and deviation reports.

5.2 Handover to QA

  1. After completion of batch manufacturing, the Production Officer shall hand over the BMR to QA.
  2. QA must log the date and time of BMR receipt in the “BMR Receipt Register” (Annexure-1).

5.3 Preliminary QA Review

  1. Check the following:
    • Batch number and product name match the production plan
    • All required fields are filled, signed, and dated
    • No overwriting or unauthorized corrections exist
    • All in-process checks are documented
    • Logbook references match the entries

5.4 Detailed QA Review Checklist

  1. Verify the following:
    • Raw materials were issued from approved stock and used within their shelf life
    • Equipment was cleaned, calibrated, and released before use
    • Critical process parameters are documented and fall within permissible ranges
    • Yield and reconciliation calculations are correct
    • Any deviations are recorded and closed with approved CAPA
    • Analytical results match the specifications
  2. Record observations in the “BMR Review Checklist” (Annexure-2).
See also  API Manufacturing: SOP for Vacuum Drying Procedure - V 2.0

5.5 Handling Deviations in BMR

  1. If entries are missing or incorrect, raise a BMR discrepancy form (Annexure-3).
  2. Discrepancy must be resolved before final approval.
  3. Corrective entries must be endorsed with initials, date, and explanation — overwriting is not allowed.

5.6 BMR Approval and Archival

  1. After all corrections, the QA Reviewer shall sign the BMR review section.
  2. QA Manager shall perform a final review and approve the batch by signing the “Approved for Release” page.
  3. The approved BMR is handed to Document Control for archiving and scanned for electronic backup.

5.7 Batch Release Decision

  1. Only after BMR is reviewed, signed, and supported by:
    • CoA
    • Deviation closure reports
    • In-process and final QC reports
  2. The batch release decision shall be documented and batch disposition updated in ERP/MIS system.

5.8 Retention of BMRs

  1. All BMRs shall be retained in a secured archive room for a minimum of 5 years or as per product shelf life.
  2. Electronic BMRs (eBMRs) shall be password protected and have limited access under QA control.

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • QC: Quality Control
  • CAPA: Corrective and Preventive Action
  • ERP: Enterprise Resource Planning
See also  API Manufacturing: SOP for Water Analysis by KF Titration - V 2.0

7. Documents

  1. BMR Receipt Register (Annexure-1)
  2. BMR Review Checklist (Annexure-2)
  3. BMR Discrepancy Form (Annexure-3)
  4. Final BMR Approval Record
  5. Batch Release Status Sheet

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211.188 – Batch Production and Control Records
  • EU GMP Guidelines – Chapter 4: Documentation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: BMR Receipt Register

Date Batch No. Product Name Received By QA Initials
13/04/2025 BCH/APR/001 API-Z Rajesh Kumar SN

Annexure-2: BMR Review Checklist

Review Parameter Yes/No Comments
Raw Material Traceability Verified Yes All CoAs Attached
Yield Calculation Accurate Yes Within limits
All Pages Signed No Page 12 signature missing

Annexure-3: BMR Discrepancy Form

Date Batch No. Discrepancy Observed Corrective Action Approved By
13/04/2025 BCH/APR/001 Omitted yield entry Updated by Supervisor QA

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New implementation QA Head
14/04/2025 2.0 Added review checklist and ERP integration Compliance upgrade QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Optimization of Injection Viscosity – V 2.0
Next Post: Elixir Department: SOP for Handling of Intermediate Product – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version